The Maurice A. Deane School of Law at Hofstra University and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell are hosting their second annual national Medical-Legal Trial Competition this weekend, November 1-3, 2019. Ten teams from well-respected law schools around the country will compete in a tournament-style competition where each team is provided a fact pattern and is assigned a medical student to play the role of an expert witness. DOAR, the leading global consulting firm providing critical insight and strategic advice to lawyers on complex legal disputes, is sponsoring the event by providing graphic and presentation support to each of the competing teams.

“We are excited to participate in this event for a second year and to support the next generation of attorneys,” said Gene Klimov, CTO and Managing Director at DOAR. “Our participation in the tournament will enable teams to access real-world trial professionals who have expertise helping top tier attorneys communicate their trial strategies most effectively.”

Each competing team must adhere to Federal Rules of Civil Procedure and Federal Rules of Evidence and can only operate within the parameters of the fact pattern and what is set forth within competition guidelines. The teams will consult with their assigned medical student as a true expert witness and prepare that witness for the trial. During the competition, the expert can be cross-examined on any materials relevant to their testimony.

“DOAR’s depth of experience working with attorneys and expert witnesses on cases has shown us that expert witness testimony can often be a determining factor in whether you win or lose a case,” said Jeff Dorfman, a former litigator, Hofstra Law alumnus, and DOAR Business Development Manager. “It will be critical for each team to collaborate with their expert to better inform their case analysis and theory and also to prep their expert on how to communicate their position clearly and concisely at the mock trial.”

The three preliminary rounds of the tournament will be held at the Nassau County Supreme Court. Following the third round of the competition, advancing teams will participate in a semifinal round and the final round held at Hofstra Law School. All rounds will be judged by practicing attorneys and/or sitting judges.

 “Last year’s trial competition demonstrated the phenomenal advocacy skills of the participating law school students, and we anticipate that this year’s competition will be nothing short of exceptional,” said Jared Rosenblatt, tournament director and faculty advisor to the Hofstra Trial Advocacy Association (HTAA). “DOAR’s contribution adds to our unique competition because it allows students to consult with a renowned litigation strategy firm to create unique exhibits. We thank DOAR for their contributions to the event and their continued support of the law profession and of future attorneys.”

About DOAR, Inc.

DOAR is the leading global consulting firm advising lawyers at top tier law firms and major corporations. We leverage our more than 30 years of experience to provide the insight, expertise, and support required to handle the most complex, high-stakes legal disputes. We stay at the forefront of the most impactful trends and technologies affecting the legal community and deliver valuable insight that informs and advances our clients’ litigation strategies.

For more information about DOAR, visit DOAR.com and follow us at @DOARlitigation.

Media Inquiries:

Cindy Siegel
Director of Marketing
media@DOAR.com

 

Stay Informed
Stay up to date on our latest news and insights.
Subscribe
Read More
celllphone image with blue light leak in top blocking out screen, insinuating social media issues with jurors
Article
Jan 9, 2026
Social Media Research on Prospective Jurors: Navigating Evolving Ethical Boundaries

As technology transforms what is possible in juror research, the gap between available tools and permissible practices continues to widen, particularly with respect to social media.

Read Now
lines of light making forward movement
Article
Dec 12, 2025
Wireless Litigation Trends at a Glance: Case Trends and Top Parties

Using aggregated filing data from the wireless dataset, we provide a data-driven view of where litigation is concentrated, which parties are most active, and how the structure of the wireless market shapes the legal landscape.

Read Now
black and white looking up at building from ground
Article
Dec 9, 2025
Why Jurisdiction Shapes What Testifying Experts Can Say Before and During Trial

State rules can dramatically alter what experts must disclose before trial and what they’re allowed to say during it. Let’s examine the spectrum of these guidelines and how they shift by location.

Read Now
looking up at a ceiling that are illuminated squares
Article
Nov 7, 2025
Know Your Fact-Finder: Not Just for Jury Trials

Research has shown that external variables can influence decision-making even for “objective” fact-finders. 

Read Now
financial ticker showing up and downward growth
Article
Oct 28, 2025
Cryptocurrency Litigation: Case Types, Segments, and Court Trends at a Glance

New data reveals how crypto disputes are playing out in courtrooms nationwide, as the fast-evolving industry faces growing legal accountability.

Read Now
a triangle pattern with dark shadows showing texture
Article
Sep 26, 2025
Key Takeaways from ALJ Johnson Hines’ Fireside Chat for ITCTLA

DOAR Director, Jeffrey Dorfman, recently attended ITCTLA's panel and procedure event and took note of ALJ Johnson Hines’s practical guidance.

Read Now
financial ticker showing upward growth
Article
Sep 24, 2025
Cryptocurrency Litigation: Parent Companies and Industry Segments at a Glance

Our latest deep dive focuses on crypto litigation an parent-company activity in federal district courts in the U.S..

Read Now
white pill dropped in water resulting in bubbles, black background
Article
Aug 18, 2025
Biologics Litigation: Administrative Judges, Key Players, and Patent Patterns at the PTAB

Across 192 biologics PTAB proceedings, a small group of APJs and repeat innovator and biosimilar companies accounts for much of the activity.

Read Now